Axonics, Inc.
Clinical trials sponsored by Axonics, Inc., explained in plain language.
-
Rechargeable implant offers hope for bladder control – but does it last?
Disease control Recruiting nowThis study is following 55 adults who have an implanted device that stimulates nerves to control overactive bladder. Researchers want to see if the device safely improves quality of life over the long term. Participants must have already tried other treatments without success.
Phase: NA • Sponsor: Axonics, Inc. • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
New device aims to quiet overactive bladder in men
Symptom relief Recruiting nowThis study tests a device called the Axonics SNM System, which uses mild electrical pulses to calm the nerves that control the bladder. It is for men with overactive bladder, including those with urgency incontinence or frequent urination. The trial will enroll 150 men and track …
Phase: NA • Sponsor: Axonics, Inc. • Aim: Symptom relief
Last updated Jun 23, 2026 11:56 UTC
-
New device trial offers hope for bladder and bowel leakage
Symptom relief Recruiting nowThis study is testing a new external device (Axonics ETS-02) to see if it is safe and works for people with overactive bladder or fecal incontinence. About 75 adults will wear the device for a short trial period. The goal is to check if the device stays attached and works properl…
Phase: NA • Sponsor: Axonics, Inc. • Aim: Symptom relief
Last updated Jun 11, 2026 12:09 UTC